Thursday 18 December 2014
 
»
Tag
 
»
Avastin

Roche's top drug rejected for breast cancer

Roche Holding's cancer drug Avastin has been rejected by Britain's healthcare cost agency as a first-line treatment for advanced breast cancer, the latest in a series of setbacks for this medicine. The National Institute for Health and Cli

More…

Fake Avastin shipped from UK to US

A new batch of counterfeit Avastin discovered in the United States was shipped from Britain after being purchased from a Turkish wholesaler by a British-based business, officials said on Wednesday. The pattern of shipments from the Middle

More…

US alerts against repackaged injections

The US Food and Drug Administration (FDA) has alerted health care professionals that repackaged intravitreal injections of Avastin (bevacizumab) have caused a cluster of serious eye infections in the Miami, Florida. The Florida Department

More…

FDA panel rejects Avastin use for breast cancer

US health advisers unanimously rejected use of the drug Avastin for breast cancer, dealing a blow to its manufacturer and patients who insisted that the medicine saved their lives. Advisers to the US Food and Drug Administration agreed tha

More…

Cheaper Roche cancer drug as good as Lucentis

Avastin, a cancer drug made by Roche Holding, was about as effective as the company's far more expensive eye drug, Lucentis, at preventing vision loss in people with age-related macular degeneration, the New York Times reported. The tw

More…

Avastin raises heart failure risk

Women with advanced breast cancer who were treated with Roche's Avastin were more likely to develop heart failure than other women, according to an analysis that raised more concerns about the already troubled drug. A team led by Dr To

More…

US, Europe place limits on Avastin use

Avastin, the world's best-selling cancer medicine, should no longer be approved for breast cancer, US officials said on Thursday in an unusual move that could shave $1 billion from manufacturer Roche's annual sales. European authorities, m

More…

US delays ruling on Roche drug

US regulators have extended by three months a review of Roche Holding's blockbuster drug Avastin in breast cancer, the company said. The Food and Drug Administration has made no decision on whether to revoke Avastin's approval for

More…

Roche drug helps ovarian cancer

Long-term use of Swiss drugmaker Roche Holding’s Avastin, in combination with chemotherapy, helped women with advanced ovarian cancer live longer without their cancer getting worse, according to results from a new study. The trial, funded

More…

Drug ‘shows positive results on ovarian cancer’

Women with advanced ovarian cancer who are treated with Roche's Avastin and chemotherapy and then continue to take Avastin live longer without their disease worsening than if they only have chemotherapy, the Swiss drugmaker said. Roche, th

More…
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads